Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Multidisciplinary Aspects of 104 Patients with Pierre Robin Sequence

View through CrossRef
Objective To describe Pierre Robin sequence patients with a cleft palate from a multidisciplinary perspective. Patients A total of 104 individuals with Pierre Robin sequence and cleft palate, born between 1980 and 2010. Method Data were collected retrospectively and compared with large control groups. Results Of 104 patients, 19 (18.3%) were treated with a nasopharyngeal or oropharyngeal tube, continuous positive airway pressure, and/or a tracheotomy. The mean weight percentile for newborns with Pierre Robin sequence was 30.9. It decreased to 29.9 at the time of cleft palate repair (mean age, 13.7 months) ( P = .78). Of 87 patients, 30 (34.5%) developed normal speech after cleft palate repair. Of 93 nonsyndromic Pierre Robin sequence patients, 31 (33.3%) had or are having surgery for velopharyngeal insufficiency, a rate that is significantly higher when compared with a control group of cleft palate–only patients (19.4%; P = .004). Of 31 patients, 25 (80.6%) developed normal resonance after surgery for velopharyngeal insufficiency. There was no significant difference in the rate of syndromes between the Pierre Robin sequence patients and a control group of cleft palate patients without Pierre Robin sequence ( P = .25). Seven of 39 boys (17.9%) with Pierre Robin sequence had a diagnosis of autism spectrum disorder. Conclusion Even though the mean weight percentile for newborns with Pierre Robin sequence was low, the patients did not show a growth spurt during the first year of life. The high rate of velopharyngeal insufficiency after cleft palate repair in patients with Pierre Robin sequence needs further investigation. Also, the high rate of autism spectrum disorder among boys with Pierre Robin sequence prompts further investigation.
Title: Multidisciplinary Aspects of 104 Patients with Pierre Robin Sequence
Description:
Objective To describe Pierre Robin sequence patients with a cleft palate from a multidisciplinary perspective.
Patients A total of 104 individuals with Pierre Robin sequence and cleft palate, born between 1980 and 2010.
Method Data were collected retrospectively and compared with large control groups.
Results Of 104 patients, 19 (18.
3%) were treated with a nasopharyngeal or oropharyngeal tube, continuous positive airway pressure, and/or a tracheotomy.
The mean weight percentile for newborns with Pierre Robin sequence was 30.
9.
It decreased to 29.
9 at the time of cleft palate repair (mean age, 13.
7 months) ( P = .
78).
Of 87 patients, 30 (34.
5%) developed normal speech after cleft palate repair.
Of 93 nonsyndromic Pierre Robin sequence patients, 31 (33.
3%) had or are having surgery for velopharyngeal insufficiency, a rate that is significantly higher when compared with a control group of cleft palate–only patients (19.
4%; P = .
004).
Of 31 patients, 25 (80.
6%) developed normal resonance after surgery for velopharyngeal insufficiency.
There was no significant difference in the rate of syndromes between the Pierre Robin sequence patients and a control group of cleft palate patients without Pierre Robin sequence ( P = .
25).
Seven of 39 boys (17.
9%) with Pierre Robin sequence had a diagnosis of autism spectrum disorder.
Conclusion Even though the mean weight percentile for newborns with Pierre Robin sequence was low, the patients did not show a growth spurt during the first year of life.
The high rate of velopharyngeal insufficiency after cleft palate repair in patients with Pierre Robin sequence needs further investigation.
Also, the high rate of autism spectrum disorder among boys with Pierre Robin sequence prompts further investigation.

Related Results

Abstract 1563: DRP-104, a broad acting glutamine antagonist, synergizes with immune checkpoint blockade in vivo
Abstract 1563: DRP-104, a broad acting glutamine antagonist, synergizes with immune checkpoint blockade in vivo
Abstract We previously reported that DRP-104, a novel broad acting glutamine antagonist, has significant therapeutic potential in cancer by directly targeting tumor ...
Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19
Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19
Abstract Background Previous retrospective research has shown that maintaining prone positioning (PP) for an average of 40 h is associated with an i...
Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores
Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores
Abstract Background Predicting outcomes of critically ill intensive care unit (ICU) patients with coronavirus-19 disease (COVID-19) is a major chall...

Back to Top